Raaj Medisafe board meets May 29 to consider FY26 results

1 min read     Updated on 20 May 2026, 05:39 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Raaj Medisafe India Limited's board meeting on May 29, 2026, will focus on approving the audited financial results for Q4 and FY26, along with financial statements and cash flow reports. The agenda also includes approving related party transactions, authorizing the conversion of physical shares to demat form, and reviewing governance reports for the quarter ended March 31, 2026.

powered bylight_fuzz_icon
40824551

*this image is generated using AI for illustrative purposes only.

Raaj Medisafe India Limited has announced that its board of directors will meet on May 29, 2026, to discuss and approve the company's financial performance for the fiscal year ending March 31, 2026. The meeting is scheduled to take place at 3:00 P.M. at the company's registered office in Ujjain.

Agenda for the Meeting

The primary focus of the meeting will be the consideration and approval of the audited financial results for the quarter and year ended March 31, 2026. The board will also review the financial statements and cash flow statements for the same period. Furthermore, the directors will take note of the draft auditors' report on the financial statements.

Other Key Business Items

In addition to the financial results, the board will consider and approve transactions with related parties entered into during the period from October 1, 2025, to March 31, 2026. The meeting will also cover the adoption of the Integrated (Finance) Report, which includes details on related party transactions and the utilization of funds raised through preferential allotment.

Governance and Compliance

The board is set to authorize the Registrar and Transfer Agents (RTA) to facilitate the conversion of physical shares into dematerialized form as per a SEBI circular dated January 30, 2026. Other agenda items include adopting the Reconciliation of Share Capital Audit and reviewing the Shareholding Pattern and Integrated (Governance) Report for the quarter ended March 31, 2026.

Historical Stock Returns for Raaj Medisafe

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%+10.99%+8.33%-5.59%+527.59%

How might Raaj Medisafe India's FY2026 financial results compare to industry peers in the medical devices and pharmaceutical packaging sector, and what growth trajectory could investors expect going forward?

What are the potential implications of the related party transactions from October 2025 to March 2026 on the company's corporate governance ratings and minority shareholder confidence?

How could the SEBI-mandated conversion of physical shares to dematerialized form impact the company's shareholder base composition and future trading liquidity on the exchange?

Raaj Medisafe India Limited Files SEBI Compliance Certificate for Q4FY26

1 min read     Updated on 10 Apr 2026, 09:37 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Raaj Medisafe India Limited submitted its quarterly compliance certificate under SEBI Regulation 74(5) for Q4FY26, covering the quarter ended March 31, 2026. The certificate from RTA Ankit Consultancy Pvt. Ltd. confirms proper handling of dematerialization processes, timely processing of securities, and adherence to regulatory requirements. This routine submission demonstrates the company's commitment to maintaining compliance with securities market regulations.

powered bylight_fuzz_icon
37382875

*this image is generated using AI for illustrative purposes only.

Raaj medisafe India Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling mandatory regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The submission, dated April 10, 2026, covers the quarter ended March 31, 2026.

Regulatory Compliance Certificate

The company submitted the confirmation certificate received from M/s. Ankit Consultancy Pvt. Ltd., which serves as the Registrar and Share Transfer Agent (RTA) for Raaj Medisafe India Limited. This certificate is mandated under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

Parameter: Details
Quarter Covered: March 31, 2026
Submission Date: April 10, 2026
RTA: Ankit Consultancy Pvt. Ltd.
SEBI Registration: INR 000000767

Certificate Confirmation Details

Ankit Consultancy Pvt. Ltd., dated April 2, 2026, confirmed several key compliance aspects for the quarter:

  • Securities received from depository participants for dematerialization were properly confirmed to depositories
  • All securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
  • Security certificates received for dematerialization were mutilated and cancelled after due verification
  • Depository names were substituted in the register of members as registered owners within the prescribed 15-day timeframe

Company Information

Raaj Medisafe India Limited, formerly known as Manoj Surgical Ind. Ltd., operates from its registered office at 75/2 and 3, Industrial Area, Maxi Road, Ujjain-456010. The company is incorporated under CIN L33112MP1985PLC003039.

Corporate Details: Information
Managing Director: Arpit Bangur (DIN: 02600716)
Registered Office: Ujjain, Madhya Pradesh
Contact: +917342518989
Website: www.raajmedisafeindia.com

The certificate submission represents routine quarterly compliance activity, ensuring adherence to securities market regulations and proper processing of dematerialization requests during the specified period.

Historical Stock Returns for Raaj Medisafe

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%+10.99%+8.33%-5.59%+527.59%

What strategic initiatives might Raaj Medisafe India Limited pursue in the medical safety sector following its recent name change from Manoj Surgical Ind. Ltd.?

How could potential changes in SEBI's depositories regulations impact the company's future compliance costs and operational processes?

Will Raaj Medisafe consider expanding its manufacturing operations beyond its current Ujjain facility to capture larger market share?

More News on Raaj Medisafe

1 Year Returns:-5.59%